Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 1 | 2010 | 110 | 0.330 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 1 | 0.240 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 15 | 0.240 |
Why?
|
| Adenoma | 1 | 2005 | 58 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 24 | 0.190 |
Why?
|
| Cryosurgery | 2 | 2013 | 16 | 0.130 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 8 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 28 | 0.130 |
Why?
|
| Scoliosis | 1 | 2016 | 31 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 88 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2015 | 30 | 0.120 |
Why?
|
| Phagocytosis | 1 | 2015 | 25 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2015 | 55 | 0.110 |
Why?
|
| Dietary Proteins | 1 | 2014 | 26 | 0.110 |
Why?
|
| Muscles | 1 | 2014 | 48 | 0.110 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 214 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 2 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2013 | 23 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2015 | 354 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 25 | 0.100 |
Why?
|
| Iodine Radioisotopes | 1 | 2012 | 13 | 0.100 |
Why?
|
| Brachytherapy | 1 | 2012 | 22 | 0.100 |
Why?
|
| Humans | 13 | 2016 | 22848 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 1 | 0.100 |
Why?
|
| Glaucoma | 1 | 2012 | 2 | 0.100 |
Why?
|
| Optic Disk | 1 | 2012 | 2 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 3 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 13 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2012 | 12 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 98 | 0.090 |
Why?
|
| Furans | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 2 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2011 | 12 | 0.090 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2010 | 2 | 0.090 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Female | 9 | 2016 | 12677 | 0.090 |
Why?
|
| Aged | 7 | 2014 | 7669 | 0.080 |
Why?
|
| Male | 9 | 2016 | 12453 | 0.080 |
Why?
|
| Adult | 6 | 2016 | 6584 | 0.080 |
Why?
|
| Algorithms | 1 | 2012 | 305 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 295 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2016 | 435 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 16 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2016 | 3062 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 138 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 2 | 0.080 |
Why?
|
| Middle Aged | 6 | 2014 | 7555 | 0.080 |
Why?
|
| ras Proteins | 1 | 2009 | 9 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 32 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2009 | 46 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 368 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 78 | 0.070 |
Why?
|
| Mutation | 1 | 2009 | 284 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 196 | 0.070 |
Why?
|
| Adolescent | 2 | 2016 | 1775 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2013 | 2960 | 0.060 |
Why?
|
| Hypophysectomy | 1 | 2005 | 3 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2006 | 85 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 31 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 168 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 470 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2015 | 22 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 119 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 401 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 305 | 0.050 |
Why?
|
| Brain | 1 | 2009 | 1324 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 4055 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 947 | 0.040 |
Why?
|
| Disease Progression | 2 | 2012 | 554 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 155 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 1774 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 1290 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2016 | 62 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2015 | 3 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 24 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 11 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 16 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 45 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 103 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 130 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 46 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 172 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 1 | 0.030 |
Why?
|
| India | 1 | 2014 | 12 | 0.030 |
Why?
|
| Anthropometry | 1 | 2014 | 28 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 40 | 0.030 |
Why?
|
| China | 1 | 2014 | 44 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 34 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 116 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 18 | 0.030 |
Why?
|
| Arm | 1 | 2014 | 80 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 125 | 0.030 |
Why?
|
| Child | 1 | 2016 | 990 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 90 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1122 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 390 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 167 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 55 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 121 | 0.020 |
Why?
|
| Palliative Care | 1 | 2012 | 94 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 30 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 400 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 60 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 1128 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2011 | 55 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 317 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 92 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 71 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 3 | 0.020 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2010 | 6 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 9 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 14 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 1721 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 30 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 44 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1220 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 320 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 5 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 7 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 162 | 0.020 |
Why?
|
| Encephalitis | 1 | 2009 | 11 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 26 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 14 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 60 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 19 | 0.020 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 3 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2009 | 10 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 23 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 16 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 94 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 20 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 109 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 166 | 0.020 |
Why?
|
| Microglia | 1 | 2009 | 89 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 157 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 181 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 133 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 3025 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 270 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 122 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 307 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 269 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 630 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 453 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 101 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 1942 | 0.010 |
Why?
|
| Dementia | 1 | 2006 | 484 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2006 | 556 | 0.010 |
Why?
|